Skip Navigation

VAERS Bibliography - January 2007

  1. Vaccine for Alzheimer's Disease?   Health News; 12 (10): 2; October, 2006.

  2. Recommendations for Institutional Prematriculation Immunizations.   J Am Coll Health; 55 (3): 126-132; November, 2006.

  3. Measles--United States, 2005.   MMWR Morb Mortal Wkly Rep; 55 (50): 1348-1351; December 22, 2006.

  4. Recommendations and Guidelines on Influenza Vaccination and Treatment. A Key Success Factor.   Vaccine; 24 (44-46): 6783-6784; November 10, 2006.

  5. Infant Immunisation With a Pneumococcal Conjugate Vaccine: From the Age of Two Months, for All Infants.   Prescrire Int; 15 (86): 227-233; December, 2006.

  6. New Immunizations for Adults.   Harv Mens Health Watch; 11 (3): 5-6; October, 2006.

  7. Baumgardner, D. J.; Halsmer, S. E.; Steber, D. L.; Shah, D. S.; Mundt, M. P.  Does Proximity to Clinic Affect Immunization Rates and Blood Pressure?   Int J Psychiatry Med; 36 (2): 199-209; 2006.

  8. Borrow, R.; Miller, E.  Long-Term Protection in Children With Meningococcal C Conjugate Vaccination: Lessons Learned.   Expert Rev Vaccines; 5 (6): 851-857; December, 2006.

  9. Canavan, B. C.; Kurilo, M.; Moss, T.; McLaren, R.; Berry, K.; Thomas, C.; Rasulnia, B.; Kelly, J.; Urquhart, G.  Immunization Information Systems Progress - United States, 2005.   MMWR Morb Mortal Wkly Rep; 55 (49): 1327-1329; December 15, 2006.

  10. Catellani, P.; Console, R.  New Frontiers of Therapy Between the 19th and 20th Centuries in the Farmacia Mazzolini: Radioactivity, Electricity, Vaccination, Anaesthesia.   Pharm Hist (Lond); 36 (1): 2-6; March, 2006.

  11. Chen, M.; Hisatomi, Y.; Furumoto, A.; Kawakami, K.; Masaki, H.; Nagatake, T.; Sueyasu, Y.; Iwanaga, T.; Aizawa, H.; Oishi, K.  Comparative Immune Response Between Responders and Low Responders in Patients With Chronic Pulmonary Diseases During the 2 Year Period After Pneumococcal Vaccination.   Clin Vaccine Immunol; December 13, 2006. [Epub ahead of print].

  12. Chu, J. Y.; Zhang, Y. P.  [Immunization Strategy for Poliomyelitis in China].   Zhonghua Liu Xing Bing Xue Za Zhi; 27 (6): 464-468; June, 2006.

  13. Collins, B. K.; Morrow, H. E.; Ramirez, J. M.; Cochran, C. E.; Smith, D. R.  Childhood Immunization Coverage in US States: the Impact of State Policy Interventions and Programmatic Support.   J Health Soc Policy; 22 (1): 77-92; 2006.

  14. Cook, V. J.; Kuramoto, L.; Noertjojo, K.; Elwood, R. K.; Fitzgerald, J. M.  BCG Vaccination and the Prevalence of Latent Tuberculosis Infection in an Aboriginal Population.   Int J Tuberc Lung Dis; 10 (12): 1347-1353; December, 2006.

  15. Coplu, N.; Esen, B.; Gozalan, A.; Kurtoglu, D.; Ishid, S.; Miyamura, K.  Immunity Against Tetanus and Effect of Vaccination in Turkey.   Scand J Infect Dis; 38 (11): 1009-1016; 2006.

  16. D'Heilly, S.; Ehlinger, E.; Nichol, K.  Predictors of Meningococcal Vaccination Among University Students.   J Am Coll Health; 55 (3): 169-173; November, 2006.

  17. Davids, V.; Hanekom, W.; Gelderbloem, S. J.; Hawkridge, A.; Hussey, G.; Sheperd, R.; Workman, L.; Soler, J.; Murray, R. A.; Ress, S. R.; Kaplan, G.  Dose-Dependent Immune Response to BCG Vaccination in Neonates.   Clin Vaccine Immunol; December, 2006. [Epub ahead of print].

  18. Dayan, G. H.; Thorley, M.; Yamamura, Y.; Rodriguez, N.; McLaughlin, S.; Torres, L. M.; Seda, A.; Carbia, M.; Alexander, L. N.; Caceres, V.; Pallansch, M. A.  Serologic Response to Inactivated Poliovirus Vaccine: a Randomized Clinical Trial Comparing 2 Vaccination Schedules in Puerto Rico.   J Infect Dis; 195 (1): 12-20; January 1, 2007.

  19. de Miguel, A. G.  [Strategies of Vaccination for Adult Population in Spain in the Actuality].   An R Acad Nac Med (Madr ); 123 (1): 175-194; 2006.

  20. Doja, A.; Roberts, W.  Immunizations and Autism: a Review of the Literature.   Can J Neurol Sci; 33 (4): 341-346; November, 2006.

  21. Eavey, J.; Tapia, R.; Sokol, T.; Ratard, R.  Childhood Immunization Rates in Louisiana: Trends From 1995-2004.   J La State Med Soc; 158 (5): 232-238; September, 2006.

  22. Elkayam, O.  Safety and Efficacy of Vaccination Against Influenza in Patients With Rheumatoid Arthritis.   Clin Dev Immunol; 13 (2): 349-351; June, 2006.

  23. Frampton, J. E.; Keating, G. M.  Reduced-Antigen, Combined Diphtheria, Tetanus, and Acellular Pertussis Vaccine (Boostrix(Trade Mark)) : A Review of Its Use As a Single-Dose Booster Immunization.   BioDrugs; 20 (6): 371-389; 2006.

  24. France, E. K.; Smith-Ray, R.; McClure, D.; Hambidge, S.; Xu, S.; Yamasaki, K.; Shay, D.; Weintraub, E.; Fry, A. M.; Black, S. B.; Shinefield, H. R.; Mullooly, J. P.; Jackson, L. A.  Impact of Maternal Influenza Vaccination During Pregnancy on the Incidence of Acute Respiratory Illness Visits Among Infants.   Arch Pediatr Adolesc Med; 160 (12): 1277-1283; December, 2006.

  25. Fredrickson, K.; McLaren, R. P.; Enger, K. S.; White, K.; Kirsch, B.; Canavan, B. C.; Zimmerman, L. A.; Bartlett, D. L.; Williams, W. G.  Influenza Vaccination Coverage Among Children Aged 6-23 Months - Six Immunization Information System Sentinel Sites, United States, 2005-06 Influenza Season.   MMWR Morb Mortal Wkly Rep; 55 (49): 1329-1330; December 15, 2006.

  26. Fry, L.; Baker, B. S.; Powles, A. V.  Psoriasis-a Possible Candidate for Vaccination.   Clin Dev Immunol; 13 (2): 361-367; June, 2006.

  27. Fukuda, K.; Kieny, M. P.  Different Approaches to Influenza Vaccination.   N Engl J Med; 355 (24): 2586-2587; December 14, 2006.

  28. Geel, A. L.; Landman, T. S.; Kal, J. A.; van Doomum, G. J.; Weimar, W.  Varicella Zoster Virus Serostatus Before and After Kidney Transplantation, and Vaccination of Adult Kidney Transplant Candidates.   Transplant Proc; 38 (10): 3418-3419; December, 2006.

  29. Glezen, W. P.  Asthma, Influenza, and Vaccination.   J Allergy Clin Immunol; 118 (6): 1199-1206; December, 2006.

  30. Gold, J. A.  Immunization Season: for More Than Just Flu.   WMJ; 105 (7): 57, 54; October, 2006.

  31. Grabenstein, J. D.; Watson, R. R.  Screening Adults for Multiple Immunization Needs.   Ann Pharmacother; 40 (12): 2247; December, 2006.

  32. Guiso, N.; Njamkepo, E.; Vie le, Sage F.; Zepp, F.; Meyer, C. U.; Abitbol, V.; Clyti, N.; Chevallier, S.  Long-Term Humoral and Cell-Mediated Immunity After Acellular Pertussis Vaccination Compares Favourably With Whole-Cell Vaccines 6 Years After Booster Vaccination in the Second Year of Life.   Vaccine; November 7, 2006. [Epub ahead of print].

  33. Heckler, R.; Baillot, A.; Engelmann, H.; Neumeier, E.; Windorfer, A.  Cross-Protection Against Homologous Drift Variants of Influenza A and B After Vaccination With Split Vaccine.   Intervirology; 50 (1): 58-62; 2007.

  34. Honeycutt, A. A.; Coleman, M. S.; Anderson, W. L.; Wirth, K. E.  Cost-Effectiveness of Hospital Vaccination Programs in North Carolina.   Vaccine; November 10, 2006. [Epub ahead of print].

  35. Hviid, A.  Postlicensure Epidemiology of Childhood Vaccination: the Danish Experience.   Expert Rev Vaccines; 5 (5): 641-649; October, 2006.

  36. Jefferson, T.  Author's Response to Influenza Vaccination: Policy v Evidence.   BMJ; 333 (7579): 1172; December 2, 2006.

  37. Jereb, M.; Karner, P.; Muzlovic, I.; Jurca, T.  Severe Tick-Borne Encephalitis in Slovenia in the Years 2001-2005: Time for a Mass Vaccination Campaign?   Wien Klin Wochenschr; 118 (23-24): 765-768; December, 2006.

  38. Jutel, M.; Cromwell, O.  Clinical Results From Vaccination With Recombinant Grass Pollen Allergens.   Clin Dev Immunol; 13 (2): 389-394; June, 2006.

  39. Karwat, K. J.; Szpotanska, M.; Szulc, Z.; Chazan, R.  [The Influence of Influenza Vaccination on Asthma and Chronic Obstructive Pulmonary Disease].  Pneumonol Alergol Pol; 74 (1): 80-83; 2006.

  40. Kayhty, H.; Auranen, K.; Nohynek, H.; Dagan, R.; Makela, H.  Nasopharyngeal Colonization: a Target for Pneumococcal Vaccination.  Expert Rev Vaccines; 5 (5): 651-667; October, 2006.

  41. Kekulawala, K. R.; Perera, B. J.; Senevirathna, J.; Perera, C. S.  Disseminated Tuberculosis Following BCG Vaccination.   Ceylon Med J; 51 (2): 72-73; June, 2006.

  42. Kelly, J. S.; Zimmerman, L. A.; Reed, K.; Enger, K. S.  Immunization Information Systems National Research and Evaluation Agenda.   J Public Health Manag Pract; 13 (1): 35-38; January, 2007.

  43. Kim, S. H.; Yeo, S. G.; Park, K. H.; Bang, J. W.; Kim, H. B.; Kim, N. J.; Jee, Y.; Cho, H.; Oh, M. D.; Choe, K. W.  The Persistence of Humoral and Cellular Immunities More Than Three Decades After Smallpox Vaccination.   Clin Microbiol Infect; 13 (1): 91-93; January, 2007.

  44. Kim, S. S.; Frimpong, J. A.; Rivers, P. A.; Kronenfeld, J. J.  Effects of Maternal and Provider Characteristics on Up-to-Date Immunization Status of Children Aged 19 to 35 Months.   Am J Public Health; December 28, 2006. [Epub ahead of print].

  45. King, J. C., Jr.; Stoddard, J. J.; Gaglani, M. J.; Moore, K. A.; Magder, L.; McClure, E.; Rubin, J. D.; Englund, J. A.; Neuzil, K.  Effectiveness of School-Based Influenza Vaccination.   N Engl J Med; 355 (24): 2523-2532; December 14, 2006.

  46. Kretsinger, K.; Broder, K. R.; Cortese, M. M.; Joyce, M. P.; Ortega-Sanchez, I.; Lee, G. M.; Tiwari, T.; Cohn, A. C.; Slade, B. A.; Iskander, J. K.; Mijalski, C. M.; Brown, K. H.; Murphy, T. V.  Preventing Tetanus, Diphtheria, and Pertussis Among Adults: Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Recommendations of the Advisory Committee on Immunization Practices (ACIP) and Recommendation of ACIP, Supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for Use of Tdap Among Health-Care Personnel.   MMWR Recomm Rep; 55 (RR-17): 1-37; December 15, 2006.

  47. Lininger, L. A.; Cullum, M. E.; Lyles, M. B.; Bienek, D. R.  The Impact of Incomplete Vaccination Schedules on the Magnitude and Duration of Protective Antigen-Specific IgG Responses in Recipients of the US Licensed Anthrax Vaccine.   Vaccine; November 13, 2006. [Epub ahead of print].

  48. Matsumura, T.; Nakayama, T.; Hamagashira, N.  Promoting Measles Vaccination in Attendees Not Yet Immunized at Day-Care Centers in Kyoto City.   Pediatr Int; 48 (6): 555-561; December, 2006.

  49. Nass, M.  Data Vs Conclusions in the Optic Neuritis Vaccination Investigation.   Arch Neurol; 63 (12): 1809-1810; December, 2006.

  50. Nevot, Falco S.; Bone, Calvo J.; Echeveria, Zudaire L.; Martorell, Aragones A.; Piquer, Gibert M.; Plaza Martin, A. M.; Ranea, Arroyo S.  [Safety of MMR Immunization in Egg-Allergic Children].    An Pediatr (Barc ); 65 (5): 508-509; November, 2006.

  51. Okan, F.; Karagoz, S.; Nuhoglu, A.  Bacillus Calmette-Guerin Vaccination in Preterm Infants.   Int J Tuberc Lung Dis; 10 (12): 1337-1341; December, 2006.

  52. Ozturk, S.; Kavuncuoglu, S.; Ozbek, S.; Vural, M.  Evaluation of Maternal Measles Antibody Titers and Response to the Measles Vaccination at the Age of 9 Months in Preterm Infants.   Eur J Pediatr; November 29, 2006. [Epub ahead of print].

  53. Petrini, B.; Bennet, R.  Cervical Mycobacterial Lymphadenitis in Swedish Children During the Post-BCG Vaccination Era.   Acta Paediatr; 96 (1): 146-147; January, 2007.

  54. Prosser, L. A.; Bridges, C. B.; Uyeki, T. M.; Hinrichsen, V. L.; Meltzer, M. I.; Molinari, N. A.; Schwartz, B.; Thompson, W. W.; Fukuda, K.; Lieu, T. A.  Health Benefits, Risks, and Cost-Effectiveness of Influenza Vaccination of Children.   Emerg Infect Dis; 12 (10): 1548-1558; October, 2006.

  55. Roper, J. D.  Get S.M.A.R.T. About Meningitis. School Meningitis Awareness Resource Tools: Vaccination Clinic Resource Guide. School Nurse News; 23 (5): 38-41; November, 2006.

  56. Schade, C. P.; Hannah, K. L.  Impact of the 2004 Influenza Vaccine Shortage on Repeat Immunization Rates.   Ann Fam Med; 4 (6): 541-547; November, 2006.

  57. Schwartz, B.; Hinman, A.; Abramson, J.; Strikas, R. A.; Allred, N.; Uyeki, T.; Orenstein, W.  Universal Influenza Vaccination in the United States: Are We Ready? Report of a Meeting.   J Infect Dis; 194 (Suppl 2): S147-S154; November 1, 2006.

  58. Shevell, M.; Fombonne, E.  Autism and MMR Vaccination or Thimerosal Exposure: an Urban Legend?   Can J Neurol Sci; 33 (4): 339-340; November, 2006.

  59. Shouval, D.  Adoptive Transfer of Immunity to HBV in Liver Transplant Patients:A Step Forward Toward the Proof of Concept for Therapeutic Vaccination or a Transient Immunologic Phenomenon?   Liver Transpl; 13 (1): 14-17; December 27, 2006.

  60. Smallpage, S. J.  Meningitis: a New Vaccine but Parents Still Ignorant About the Disease.   J Fam Health Care; 16 (5): 131-132; 2006.

  61. Stojanovich, L.  Influenza Vaccination of Patients With Systemic Lupus Erythematosus (SLE) and Rheumatoid Arthritis (RA).   Clin Dev Immunol; 13 (2): 373-375; June, 2006.

  62. Swain, B. K.; Mishra, S.  Immunization Coverage Among Migrant Tribal Children in Slums of Orissa.   Indian Pediatr; 43 (11): 1011-1013; November, 2006.

  63. Takahashi, Y.; Matsuda, K.; Kubota, Y.; Shimomura, J.; Yamasaki, E.; Kudo, T.; Fukushima, K.; Osaka, H.; Akasaka, N.; Imamura, A.; Yamada, S.; Kondo, N.; Fujiwara, T.  Vaccination and Infection As Causative Factors in Japanese Patients With Rasmussen Syndrome: Molecular Mimicry and HLA Class I.   Clin Dev Immunol; 13 (2): 381-387; June, 2006.

  64. Temte, J.; Campos-Outcalt, D.  Family Physicians and Immunizations.   Am Fam Physician; 74 (12): 2027-2028; December 15, 2006.

  65. Thompson, K. M.; Tebbens, R. J.  Retrospective Cost-Effectiveness Analyses for Polio Vaccination in the United States.   Risk Anal; 26 (6): 1423-1440; December, 2006.

  66. Trotter, C. L.; Ramsay, M. E.  Vaccination Against Meningococcal Disease in Europe: Review and Recommendations for the Use of Conjugate Vaccines.   FEMS Microbiol Rev; December 1, 2006. [Epub ahead of print].

  67. Valour, F.; Maulin, L.; Ader, F.; Perpoint, T.; Champagne, H.; David, G.; Boibieux, A.; Biron, F.; Peyramond, D.; Chidiac, C.  [Vaccination Against Influenza: Results of a Study on Vaccination Coverage Among Health Care Workers in the Croix-Rousse Hospital (Hospitals of Lyon).]   Med Mal Infect; December 7, 2006. [Epub ahead of print].

  68. Venkatesan, P.; Jayakumar, S.; Sharief, N.   Selective Neonatal BCG Vaccination-a Re-Audit.   Acta Paediatr; 96 (1): 145-149; January, 2007.

  69. Vijayaraghavan, M.; Martin, R. M.; Sangrujee, N.; Kimani, G. N.; Oyombe, S.; Kalu, A.; Runyago, A.; Wanjau, G.; Cairns, L.; Muchiri, S. N.  Measles Supplemental Immunization Activities Improve Measles Vaccine Coverage and Equity: Evidence From Kenya, 2002.   Health Policy; December 13, 2006. [Epub ahead of print].

  70. Wahid, R.; Salerno-Goncalves, R.; Tacket, C. O.; Levine, M. M.; Sztein, M. B.  Cell-Mediated Immune Responses in Humans After Immunization With One or Two Doses of Oral Live Attenuated Typhoid Vaccine CVD 909.   Vaccine; November 3, 2006. [Epub ahead of print].

  71. Zimmerman, R. K.; Hoberman, A.; Nowalk, M. P.; Lin, C. J.; Greenberg, D. P.; Weinberg, S. T.; Ko, F. S.; Fox, D. E.  Improving Influenza Vaccination Rates of High-Risk Inner-City Children Over 2 Intervention Years.   Ann Fam Med; 4 (6): 534-540; November, 2006.